Alderley Park Ventures

Alderley Park Ventures is a venture capital fund focused on early-stage life science and healthcare companies. Established in 2014 by AstraZeneca and Manchester Science Partnerships, the fund is managed by Pioneer Group (formerly BioCity). It provides seed and pre-seed funding to startups located at or moving to the Alderley Park innovation campus in Cheshire, UK. The fund targets high-growth businesses in drug discovery, diagnostics, and medical devices, offering not only capital but also access to specialized laboratory facilities and business support. Notable portfolio companies include BiVictriX Therapeutics, NanoSyrinx, and Alderley Analytical. The fund plays a critical role in fostering the biotech ecosystem in the North West of England.